Benign neoplasm: Ciliary body

CD2_BENIGN_CILIARY

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D31.4&
  • Cause of death: ICD-10 — D31.4&

2 out of 7 registries used, show all original rules.

117

4. Check minimum number of events

None

117

5. Include endpoints

None

117

6. Filter based on genotype QC (FinnGen only)

115

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D31
Name in latin
Neoplasma benignum corporis ciliaris

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 562 332 227
Only index persons 535 325 210
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 61.29 61.05 61.90
Only index persons 61.53 61.28 61.92

-FinnGen-

Key figures

All Female Male
Number of individuals 115 65 50
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 64.48 60.69 69.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
117
Matched controls
1170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
+∞
168.9
117
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
53.6
77.9
48
15
CH2S4
NOMESCO Finland
Photography of iris
+∞
27.1
25
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
43.3
26.3
32
10
XCK10
NOMESCO Finland
Photography of fundus of eye
8.4
24.7
41
71
Z3229
NOMESCO Finland
Other healthcare associate professional
7.1
17.0
30
54
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.7
14.3
47
147
CH3S4
NOMESCO Finland
Photography of iridocorneal angle
+∞
11.6
11
*
CD2S4
NOMESCO Finland
Photography of eye
48.3
11.2
13
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
66.2
10.8
12
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.1
10.0
19
36
H21.3
ICD-10 Finland
Cyst of iris, ciliary body and anterior chamber
+∞
9.5
9
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
9.5
9
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
26.5
9.1
12
5
H21.8
ICD-10 Finland
Other specified disorders of iris and ciliary body
73.7
6.5
7
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
73.7
6.5
7
*
H21.9
ICD-10 Finland
Disorder of iris and ciliary body, unspecified
+∞
6.3
6
*

TimeCodeWAS

↥

TimeCodeWAS is a tool for exploring time-dependent associations between an endpoint and health codes (diagnoses, lab tests, procedures, etc.).

The TimeCodeWAS analysis is done in three steps:

  1. Build a matched case-control set for this endpoint. Each case is matched to 5–10 controls on sex and year of birth, and controls must be at risk at the same age as the case's age of onset. TimeCodeWAS allows for controls to be reused.
  2. Count cases and controls. For each health code, and for each time window: tally the counts into a 2×2 table. To be eligible in a time window, a case or control must have data coverage for at least 50% of that time window.
  3. Perform association tests. If all cells of the 2×2 table have N≥10, then a χ² test is performed, otherwise a Fisher's exact test is done. The corresponding p-value and confidence interval are reported below, along with the standard odds ratio when a χ² test is done, or Fisher's MLE odds ratio otherwise.

TimeCodeWAS currently uses the same default set of time windows for all the endpoints. Please reach out to us if you have suggestions for better time windows for some endpoints. The default time windows are: TimeCodeWAS time windows

Sort & Filter
Sort
Odds Ratio
among windows:
Filter
Code & OMOP
Cases and controls with code
in
Odds Ratio
in
OMOP Concept
Code (OMOP Vocabulary) [OMOP Concept ID]
OMOP Concept Class / OMOP Domain
Odds Ratio
TimeCodeWAS O.R. time legend
Cases and controls with code
TimeCodeWAS Cases and Controls percentages time legend
Outpatient Visit
OP (Visit) [9202]
Visit / Visit
2.4e-01 2.9e-01 6.3e-01 5.5e+00 7.4e-01 8.8e-01 1.1e+00
80.34%/76.24% 64.96%/58.12% 21.37%/12.65% 52.14%/0.43% 19.66%/10.49% 73.87%/53.98% 92.13%/79.63%
Case Management Agency
251B00000X (NUCC) [38004193]
Visit / Visit
-7.0e-02 1.9e-01 6.4e-01 3.7e+00 3.2e-01 8.9e-02 1.6e-01
66.67%/68.21% 67.52%/63.33% 43.59%/28.97% 45.30%/2.05% 35.04%/28.12% 65.77%/63.74% 79.78%/77.08%
Photography of fundus of eye
XCK10 (NCSPfi) [2001301381]
NCSPfi Level 3 / Procedure
7.1e-01 2.1e+00 — 1.0e+50 — 3.2e+00 2.4e+00
4.27%/2.14% 5.13%/0.68% —/— 21.37%/0.00% —/— 9.91%/0.45% 19.10%/2.08%
Ophthalmology
18 (Medicare Specialty) [38004463]
Physician Specialty / Provider
6.9e-01 2.1e+00 2.5e+00 1.0e+50 2.5e+00 2.8e+00 2.2e+00
30.77%/18.21% 41.03%/7.52% 14.53%/1.37% 95.73%/0.00% 11.97%/1.12% 60.36%/8.42% 71.91%/21.64%
Optical coherence tomography (OCT) of ocular fundus
CK2X4 (NCSPfi) [2001301456]
NCSPfi Level 2 / Procedure
— 2.1e+00 — 1.0e+50 — 2.5e+00 1.7e+00
—/— 5.13%/0.68% —/— 5.13%/0.00% —/— 7.21%/0.63% 8.99%/1.74%
Examination of eyes and vision
Z01.0 (ICD10) [45566391]
ICD10 code / Procedure
9.2e-01 2.5e+00 — 1.0e+50 — 1.7e+00 1.7e+00
5.98%/2.48% 9.40%/0.85% —/— 5.98%/0.00% —/— 8.11%/1.52% 19.10%/4.05%
Medical doctor
Z2221 (NCSPfi) [2001311556]
NCSPfi Level 3 / Procedure
6.6e-01 1.6e+00 — 1.0e+50 — 2.4e+00 2.1e+00
8.55%/4.62% 5.13%/1.03% —/— 17.95%/0.00% —/— 9.01%/0.90% 20.22%/2.89%
Other investigative procedure of eye
XCW99 (NCSPfi) [2001301491]
NCSPfi Level 3 / Procedure
— — — — — 2.4e+00 —
—/— —/— —/— —/— —/— 5.41%/0.54% —/—
Left side
ZXA05 (NCSPfi) [2001311347]
NCSPfi Level 3 / Procedure
— — — 1.0e+50 — 2.3e+00 1.9e+00
—/— —/— —/— 4.27%/0.00% —/— 9.01%/0.98% 13.48%/2.20%

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
54
347
2.03
3.45
5.1
5.8
—
—
—
0
0
7
13
5.65
2.91
1.0
1.3
—
—
—
0
0
20
105
2.09
2.11
2.0
3.0
69.56
73.62
e9/l
0.24
12
79
6
16
3.89
1.96
1.5
1.8
30.33
31.63
pg
—
6
16
60
468
1.58
1.63
14.0
12.5
0.00
0.00
e9/l
0.84
48
387
26
167
1.72
1.51
1.3
1.3
—
—
—
0
0
90
783
1.65
1.45
4.4
4.6
14.80
14.75
pmol/l
0.06
83
705
108
999
2.05
1.44
17.5
16.9
20.03
23.44
mg/l
0.49
91
835
6
133
0.42
1.39
2.7
5.1
2.63
9.50
ug/l
—
6
107
21
130
1.75
1.38
1.4
1.2
—
—
—
0
0
32
226
1.57
1.29
5.5
3.7
64.44
244.58
ng/l
0.69
27
183
26
176
1.61
1.24
3.2
3.0
1.45
2.23
e6/l
0.32
11
90
19
118
1.73
1.24
3.2
2.3
92.36
188.10
ug/g
1.02
14
95
31
222
1.54
1.17
2.1
1.9
515.96
439.43
pmol/l
0.89
26
181
0
36
0.00
1.16
0.0
3.5
—
166.73
—
0
15
15
90
1.76
1.10
4.1
3.6
—
—
—
0
0
5
21
2.44
1.10
2.4
3.2
—
—
—
0
0
109
1029
1.87
1.01
16.3
15.2
—
—
—
0
0
44
349
1.42
0.99
5.4
4.3
7.40
7.40
ph
0.12
28
242
94
853
1.52
0.99
25.7
21.2
13.96
13.69
%
0.80
94
847
7
36
2.00
0.99
1.1
1.2
1.57
1.60
g/l
—
7
36
52
426
1.40
0.97
2.1
2.1
—
—
—
0
0
64
544
1.39
0.96
6.9
7.6
1.21
1.21
mmol/l
0.25
53
466
41
323
1.41
0.96
7.1
7.4
—
—
—
0
0
7
37
1.95
0.96
1.3
1.2
0.77
0.88
g/l
—
7
37
7
37
1.95
0.96
1.0
1.2
—
—
—
0
0
40
314
1.42
0.95
3.9
3.1
0.37
0.42
e6/l
0.07
31
232
39
306
1.41
0.93
2.7
2.8
—
0.29
—
0
7
14
87
1.69
0.92
5.9
4.5
1.22
1.22
mmol/l
—
9
71
59
498
1.37
0.91
5.2
6.7
1.22
1.21
mmol/l
0.37
53
453
74
648
1.39
0.91
3.5
5.3
6.67
6.79
mmol/l
0.16
69
620
62
528
1.37
0.90
20.0
13.4
1.27
1.25
inr
0.13
56
434
17
245
0.64
0.89
2.5
4.0
1.01
1.02
kg/l
0.31
12
169
6
31
1.98
0.85
1.8
1.8
8.77
8.04
kpa
—
6
31
48
395
1.36
0.85
3.9
3.6
—
—
—
0
0
6
32
1.92
0.83
1.2
1.2
—
—
—
0
0
101
941
1.54
0.81
5.7
5.6
1.86
1.92
mu/l
0.20
93
856
64
554
1.34
0.81
6.6
6.5
0.19
0.20
e9/l
0.20
56
485
0
27
0.00
0.78
0.0
5.0
—
29.36
—
0
21
5
23
2.22
0.77
1.0
2.6
6.86
9.07
pmol/l
—
5
23
18
126
1.51
0.76
1.1
1.4
—
—
—
0
0
7
38
1.89
0.75
1.0
1.2
—
—
—
0
0
11
168
0.62
0.74
1.5
1.7
—
—
—
0
0
42
500
0.75
0.74
2.5
2.7
—
—
estimate
—
0
0
5
26
1.96
0.71
1.6
2.0
93.98
90.23
%
—
5
26
7
43
1.67
0.68
1.4
2.0
—
—
—
0
0
61
534
1.30
0.67
5.7
6.3
0.64
0.59
e9/l
0.56
51
459
53
459
1.28
0.62
1.9
2.0
1.18
1.36
mmol/l
0.99
41
384
61
539
1.28
0.61
5.7
6.3
0.05
0.04
e9/l
1.17
51
462
0
23
0.00
0.59
0.0
1.6
—
222.29
—
0
13
103
978
1.44
0.58
6.9
7.0
38.81
39.71
mmol/mol
0.82
97
922
11
74
1.54
0.55
1.9
2.7
7.43
7.43
ph
—
6
59
6
96
0.60
0.55
3.0
9.0
—
—
—
0
0
9
62
1.49
0.54
1.0
1.3
—
—
—
0
0
61
547
1.24
0.51
5.7
6.3
2.42
1.86
e9/l
0.30
52
487
7
47
1.52
0.48
1.0
1.2
—
—
—
0
0
41
356
1.23
0.45
4.9
5.3
1.53
1.94
ug/l
1.00
35
316
74
683
1.23
0.45
4.3
4.4
—
336.33
—
0
12
8
58
1.41
0.42
2.3
3.9
4.38
4.53
pmol/l
—
8
51
11
79
1.43
0.42
2.4
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
262.89
—
0
9
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
24
198
1.27
0.40
1.1
1.4
98.92
30.82
iu/ml
—
6
68
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
39
439
0.83
0.37
3.6
3.8
0.00
0.03
estimate
0.50
11
95
5
77
0.63
0.37
3.6
3.9
—
—
—
0
0
5
79
0.62
0.37
3.4
4.6
—
—
—
0
0
6
41
1.49
0.36
1.7
2.6
1.03
1.55
mg/l
—
6
35
41
365
1.19
0.34
4.0
3.3
14.31
211.24
e6/l
0.58
31
282
6
88
0.66
0.34
1.2
1.1
—
—
—
0
0
41
452
0.86
0.29
4.2
4.1
28.81
156.85
ng/l
0.52
21
327
31
348
0.85
0.28
2.2
2.3
—
—
—
0
0
8
66
1.23
0.27
1.5
1.3
—
—
—
0
0
64
600
1.15
0.27
12.1
10.4
3.98
4.09
e9/l
0.18
52
521
103
1002
1.23
0.24
5.7
5.6
4.53
4.62
mmol/l
0.42
96
926
5
41
1.23
0.22
2.4
2.1
22.42
25.77
mmol/l
—
5
41
35
383
0.88
0.22
3.9
4.3
3.08
7.48
mg/mmol
1.35
22
227
28
311
0.87
0.21
3.4
4.2
0.00
0.02
estimate
0.50
17
104
22
193
1.17
0.21
2.6
1.7
1100.54
1261.15
nmol/l
0.29
13
142
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
44
408
1.13
0.20
4.8
3.9
16.63
52.78
e6/l
1.09
33
291
6
48
1.26
0.20
1.2
1.4
—
—
—
0
0
60
568
1.12
0.19
3.4
3.9
0.00
0.00
estimate
-0.00
17
113
5
66
0.75
0.17
2.8
3.9
144.40
126.88
g/l
—
5
66
5
65
0.76
0.17
3.8
3.0
24.20
24.49
mmol/l
—
5
65
102
998
1.17
0.17
5.6
5.5
1.47
1.48
mmol/l
0.11
94
910
104
1019
1.19
0.17
6.3
6.3
2.66
2.67
mmol/l
0.03
95
938
17
149
1.16
0.17
3.0
7.9
105.18
104.04
mmol/l
0.63
17
149
13
111
1.19
0.16
1.3
1.3
—
—
—
0
0
8
71
1.14
0.16
1.1
1.5
—
—
—
0
0
34
315
1.11
0.16
1.6
1.7
21.01
20.97
nmol/l
0.01
25
255
9
79
1.15
0.15
1.2
1.7
0.80
1.15
g/l
—
9
72
60
573
1.10
0.15
3.4
3.9
0.00
0.00
estimate
-0.00
16
102
59
564
1.09
0.14
3.4
3.9
0.00
0.00
estimate
-0.00
16
111
12
103
1.18
0.14
1.3
1.6
—
—
—
0
0
11
94
1.19
0.13
2.6
2.0
9.35
9.94
g/l
0.23
11
85
10
116
0.85
0.12
1.2
1.6
—
—
—
0
0
101
992
1.13
0.12
5.5
5.4
5.82
5.99
mmol/l
0.90
89
914
30
320
0.92
0.11
2.9
2.8
—
—
—
0
0
13
146
0.88
0.11
1.3
1.6
—
—
—
0
0
98
963
1.11
0.10
4.6
4.6
1.16
1.28
mmol/l
1.22
90
876
37
389
0.93
0.10
3.1
3.3
7.89
7.74
mmol/l
0.07
32
314
45
469
0.93
0.09
2.2
2.2
94.31
95.71
pmol/l
0.04
19
228
6
54
1.12
0.09
2.0
1.9
—
—
—
0
0
24
256
0.92
0.08
1.0
1.3
0.44
1.37
u/ml
—
5
69
6
57
1.06
0.08
3.5
3.5
1.02
1.02
ratio
—
6
51
26
245
1.08
0.08
1.8
1.8
1.72
1.77
mg/l
0.02
18
211
8
74
1.09
0.07
3.8
7.2
25.14
25.26
mmol/l
—
8
74
36
375
0.94
0.07
3.1
3.5
21.48
55.77
mg/l
1.74
22
238
9
101
0.88
0.06
2.9
7.5
9.62
9.70
mmol/l
—
9
96
9
100
0.89
0.06
1.8
1.5
—
—
—
0
0
24
249
0.95
0.03
7.3
5.8
—
—
—
0
0
11
103
1.08
0.02
2.7
7.8
0.96
1.17
mmol/l
1.04
11
103
13
137
0.94
0.01
1.3
1.4
—
—
—
0
0
13
137
0.94
0.01
2.9
8.6
7.42
7.41
ph
—
7
89
33
332
0.99
0.00
3.7
3.0
0.00
0.00
estimate
-0.00
17
94
45
448
1.01
0.00
3.0
3.6
6.02
6.16
ph
0.45
23
258
12
117
1.03
0.00
1.2
1.8
—
—
—
0
0
29
289
1.00
0.00
1.4
1.4
—
—
—
0
0
22
217
1.02
0.00
3.1
3.1
0.69
0.77
ug/l
—
10
143
23
234
0.98
0.00
1.2
1.5
2.06
2.92
g/l
1.08
14
133
17
169
1.01
0.00
1.3
1.9
—
—
—
0
0
30
296
1.02
0.00
5.1
4.7
—
—
—
0
0
15
151
0.99
0.00
1.1
1.4
—
556.47
—
0
34
0
5
0.00
0.00
0.0
3.0
—
25.80
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
58.20
—
0
5
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
52.8
—
101.80
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
9.6
—
16.42
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
7.34
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
20.4
—
720.75
—
0
8
0
7
0.00
-0.00
0.0
1.1
—
233.00
—
0
7
5
49
1.02
-0.00
2.4
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
23.67
—
0
6
0
7
0.00
-0.00
0.0
2.1
—
7.06
—
0
7
0
8
0.00
-0.00
0.0
2.1
—
75.38
—
0
8
0
7
0.00
-0.00
0.0
3.3
—
5.46
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
1531.67
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
67.50
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CILIARY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CILIARY.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CILIARY – Benign neoplasm: Ciliary body

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data